Targeted Panels Tailored for Cancer Research
Illumina offers a broad portfolio of cancer panels and cancer-focused products across multiple application areas. These products have been optimized with clinical cancer research in mind.
Achieve sequence-ready libraries from as little as 1 ng of high-quality input or 10 ng formalin-fixed paraffin-embedded (FFPE) sample using efficient, optimized assays and integrated sequencing and bioinformatics. Our comprehensive offering includes both fixed panels and custom options.
Cancer Panels for Targeted Sequencing
Our Cancer Panel Products
AmpliSeq for Illumina and our TruSight cancer panels offer several library preparation, sequencing, and data analysis options for cancer research. Streamlined library prep workflows and flexible kit configurations accommodate multiple study designs.
Select your application area below to find out more about our product offerings for cancer research.
Library Preparation
TruSight Oncology 500
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
TruSight Tumor 170
Comprehensive next-generation sequencing (NGS) assay that targets DNA and RNA variants from the same FFPE sample.
TruSight Oncology UMI Reagents
The TruSight Oncology UMI Reagents and UMI Error Correction App reduce error rates in samples to ≤0.007%, enabling the detection of low frequency variants.
AmpliSeq for Illumina Focus Panel
Targeted DNA and RNA panel investigating 52 genes with known relevance to solid tumors.
AmpliSeq for Illumina Comprehensive Panel v3
Targeted DNA and RNA panel investigating variants across 161 genes associated with a range of cancer types.
TruSight Tumor 15
Focused sequencing panel to assess 15 genes that are commonly mutated in solid tumors in a single assay, with a simple, rapid workflow.
TruSight RNA Fusion
Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
AmpliSeq for Illumina Cancer Hotspot Panel v2
Targeted panel investigating hotspot regions of 50 genes with known associations to cancer.
AmpliSeq for Illumina Comprehensive Cancer Panel
Targeted panel investigating the exonic regions of 409 genes with known associations to cancer.
AmpliSeq for Illumina Custom Panel
Targeted custom panel optimized for specific targets or genomic content of interest.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Library Preparation
TruSight Myeloid
The TruSight Myeloid Sequencing Panel targets variants associated with myeloid malignancies such as AML, MDS, MPN, CML, CMML, and JMML.
AmpliSeq for Illumina Myeloid
Targeted panel to investigate 40 DNA genes, 29 RNA fusion driver genes, and 5 gene expression levels associated with myeloid cancers.
TruSight Oncology UMI Reagents
The TruSight Oncology UMI Reagents and UMI Error Correction App reduce error rates in samples to ≤0.007%, enabling the detection of low frequency variants.
TruSight RNA Fusion
Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
AmpliSeq for Illumina Custom Panel
Targeted custom panel optimized for specific targets or genomic content of interest.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Library Preparation
TruSight Cancer
This expert-defined sequencing panel targets 94 genes and 284 SNPs associated with a predisposition towards various cancers.
AmpliSeq for Illumina BRCA Panel
Targeted panel investigating somatic and germline variants in BRCA1 and BRCA2.
AmpliSeq for Illumina Custom Panel
Targeted custom panel optimized for specific targets or genomic content of interest.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Library Preparation
TruSight RNA Pan-Cancer
Targeting 1385 cancer genes for gene expression, variant, and fusion detection studies in many RNA sample types including blood, bone marrow, and formalin-fixed, paraffin-embedded (FFPE) tissue.
TruSight Oncology UMI Reagents
The TruSight Oncology UMI Reagents and UMI Error Correction App reduce error rates in samples to ≤0.007%, enabling the detection of low frequency variants.
TruSight RNA Fusion
Provides comprehensive gene fusion detection in formalin-fixed, paraffin-embedded (FFPE) and other cancer research samples.
AmpliSeq for Illumina Cancer Hotspot Panel v2
Targeted panel investigating hotspot regions of 50 genes with known associations to cancer.
AmpliSeq for Illumina Comprehensive Cancer Panel
Targeted panel investigating the exonic regions of 409 genes with known associations to cancer.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Library Preparation
AmpliSeq for Illumina Immune Response Panel
Targeted RNA expression panel investigating 395 genes involved in tumor-immune system interactions.
AmpliSeq for Illumina Custom Panel
Targeted custom panel optimized for specific targets or genomic content of interest.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Library Preparation
TruSight RNA Pan-Cancer
Targeting 1385 cancer genes for gene expression, variant, and fusion detection studies in many RNA sample types including blood, bone marrow, and formalin-fixed, paraffin-embedded (FFPE) tissue.
AmpliSeq for Illumina Custom Panel
Targeted custom panel optimized for specific targets or genomic content of interest.
Sequencing
MiSeq System
Desktop sequencer featuring a simple NGS workflow, integrated data analysis software, and unmatched accuracy.
MiSeqDx System in Research Mode
FDA-cleared in vitro diagnostic NGS system that also operates in research mode to generate accurate, reliable data.
MiniSeq System
Simple, affordable solution for low-throughput targeted cancer sequencing.
NextSeq 550 System
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.
NextSeq 550Dx System in Research Mode
FDA regulated, CE-IVD, next-generation sequencing system that also runs in research mode to enable high-throughput clinical research.
iSeq 100 System
Affordable, fast, and accessible sequencing power for targeted or small genome sequencing in any lab.
Data Analysis and Storage
Local Run Manager
Easy-to-use software for automated on-instrument data analysis.
BaseSpace Sequence Hub
The Illumina genomics computing environment for NGS data analysis and management.
Exclusive Offer for TruSight Oncology 500
Purchase the TruSight Oncology 500 assay for the first time and receive an exclusive limited time offer.
Learn More
How Researchers Use Illumina Cancer Panels
Multisite Validation of Solid Tumor Panel
Multi-Site Analytical Validation of TruSight Tumor 15 (TST15) Determining Robustness and Concordance
Read PaperNew Views of Cancer Pathways in Pediatric Leukemia
Researchers are using the TruSight RNA Pan-Cancer Panel to understand the role of fusion genes in pediatric leukemia.
Read ArticleAccurate Identification of Cancer Biomarkers
Dr Ravindra Kolhe and his team use TruSight Tumor 170 to study a wide number of variants associated with solid tumors.
Read ArticleComprehensive Genomic Profiling (CGP)
This NGS approach consolidates hundreds of cancer-related biomarkers, including different variant types, into a single assay. Explore the benefits and find out how it compares to other NGS methods.
Recent Developments in Cancer Research
Merging discovery with clinical care at Ontario Institute for Cancer Research
Inside the Canadian icon pushing the boundaries of precision oncology
Read Article
Using analytics to improve cancer diagnosis and therapy selection
Developing and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians.
Read Interview
Understanding Indonesia’s unique cancer problem
A diverse country with younger-than-average cancer patients launches a national initiative to understand the genetics of oncology
Read ArticleAdditional Resources
Removing Cancer's Veil: TruSight Tumor 170
A new enrichment-based cancer research assay interrogates both DNA and RNA, detecting small variants, gene amplifications, gene fusions, and splice variants.
Resources for Onboarding NGS
View educational resources from recognized oncology experts and regulatory bodies about onboarding NGS.
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Amplicon Sequencing
Ultra-deep sequencing of PCR amplicons enables analysis of specific genomic regions of interest.
Cancer Panels Demonstrate Value in Tumor Studies
Clinical researchers share how TruSight Tumor 170 and TruSight Oncology 500 can play an important role in tumor characterization.
Analyze Germline CNVs with TruSight Hereditary Cancer Panel
See how the TruSight Hereditary Cancer Panel can help you analyze copy number variations with a predisposition towards cancer.